Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- ChecktodayChange DetectedNew history entries for May 9–15, 2026 add Contacts/Locations, Study Status, and Arms and Interventions sections, along with a new Revision: v3.5.4. This update appears to supersede the prior Revision: v3.5.3.SummaryDifference0.3%

- Check7 days agoChange DetectedAdded entries for Contacts/Locations and Study Status in the study record history, indicating updates to those sections within the version history.SummaryDifference0.2%

- Check14 days agoChange DetectedA new version entry dated 2026-05-01 adds Contacts/Locations and Study Status to the study record history. It also references a 2026-04-30 addition and a deletion on 2026-04-24.SummaryDifference0.1%

- Check21 days agoChange DetectedThe record history page reflects routine updates to the displayed version list and site/view revision information (moving from one revision/version label to the next). It also includes new/removed entries around recent submission dates for contacts and study status in the history log.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded Contacts/Locations and Study Status sections. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check36 days agoChange DetectedNew version history entries 223–226 were added, including updates to Study Status and Contacts/Locations.SummaryDifference0.3%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.